[Skip to Content]
[Skip to Content Landing]
Article
November 16, 1994

The Relationship of Postoperative Delirium With Psychoactive Medications

Author Affiliations

From the Section for Clinical Epidemiology (Drs Marcantonio, Goldman, Mangione, Cook, Orav, Lee, and Ms Ludwig), Divisions of General Medicine (Drs Marcantonio, Goldman, Mangione, and Lee), Gerontology (Dr Marcantonio), and Cardiology (Drs Goldman and Lee), Departments of Medicine and Anesthesia (Drs Lind and Katz), and the Clinical Initiatives Development Program (Dr Lee), Brigham and Women's Hospital, Harvard Medical School, Boston, Mass; Department of Epidemiology, Harvard School of Public Health, Boston (Drs Cook and Goldman); and Department of Anesthesia, Cedars Sinai Medical Center, Los Angeles, Calif (Dr Juarez). Dr Mangione is now with the UCLA Medical Center, Los Angeles, Calif. Dr Lind is now with the University of Cincinnati (Ohio) Medical Center.

JAMA. 1994;272(19):1518-1522. doi:10.1001/jama.1994.03520190064036
Abstract

Objective.  —To examine the role of medications with known psychoactive properties in the development of postoperative delirium.

Design.  —Nested case-control study within a prospective cohort study.

Setting.  —General surgery, orthopedic surgery, and gynecology services at Brigham and Women's Hospital, Boston, Mass.

Patients.  —Cases (n=91) were patients enrolled in a prospective cohort study who developed delirium during postoperative days 2 through 5. One or two controls (n=154) were matched to each case by the calculated preoperative risk for delirium using a predictive model developed and validated in the prospective cohort study.

Main Outcome Measures.  —Medication exposures were ascertained from the medical record by a reviewer blinded to the study hypothesis. Exposures to narcotics, benzodiazepines, and anticholinergics were recorded for the 24-hour period before delirium developed in the 91 cases and for the same 24-hour postoperative period for the 154 matched controls.

Results.  —Delirium was significantly associated with postoperative exposure to meperidine (odds ratio [OR], 2.7; 95% confidence interval [CI], 1.3 to 5.5) and to benzodiazepines (OR, 3.0; 95% CI, 1.3 to 6.8). Meperidine had similar associations with delirium whether administered via epidural or patient-controlled routes, although only the epidural route reached significance (OR, 2.4; 95% CI, 1.3 to 4.4; OR, 2.1; 95% CI, 0.4 to 10.7, respectively). For benzodiazepines, long-acting agents had a trend toward stronger association with delirium than did short-acting agents (OR, 5.4; 95% CI, 1.0 to 29.2; vs 2.6; 1.1 to 6.5), and high-dose exposures had a trend toward slightly stronger association than low-dose exposures (OR, 3.3; 95% CI, 1.0 to 11.0; vs 2.6; 0.8 to 9.1). Neither narcotics (OR, 1.4; 95% CI, 0.5 to 4.3) nor anticholinergic drugs (OR, 1.5; 95% CI, 0.6 to 3.4) were significantly associated with delirium as a class, although statistical power was limited because of the high use of narcotics and the low use of anticholinergics in the study population.

Conclusions.  —Clinicians caring for patients at risk for delirium should carefully evaluate the need for meperidine and benzodiazepines in the postoperative period and consider alternative therapies whenever possible.(JAMA. 1994;272:1518-1522)

×